Cargando…
Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron
[Image: see text] Chronic transfusion of red blood cells (RBCs) to patients with β-thalassemia, sickle cell disease, and other acquired anemic disorders generates significant amounts of bioactive iron deposits in the body. The inactivation and excretion of redox active iron(III) from the blood pool...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2019
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535967/ https://www.ncbi.nlm.nih.gov/pubmed/31139728 http://dx.doi.org/10.1021/acscentsci.9b00284 |